Simulation-driven firmware development decouples code from hardware constraints, enabling earlier testing and faster delivery ...

Maximilian Holland, research associate, and Marion Früchtl, head of cross competence field, Fraunhofer Institute for Casting, Composite and Processing Technology (IGCV) Figure 1: The design of a ...

The potential of companies developing artificial intelligence (AI)-based tools for drug discovery and development has driven investment and deals with major biopharma companies, but challenges for AI ...

In today’s dynamic business environment, traditional applications pose significant challenges; hampering agility, scalability, and efficiency — which are all key attributes that organizations strive ...

AI drives decision inputs: In 2025, both big pharma and small pharma use advanced predictive modeling, digital twins, and AI-powered analytics throughout R&D and regulatory processes. This reduces ...